Prior information notice
This notice is for prior information only
Section I: Contracting
authority
I.1) Name and addresses
Airedale NHS Foundation Trust
Skipton Road
Kieghley
BD20 6TD
UK
Contact person: Xander Mcconville
Telephone: +44 1535294510
E-mail: xander.mcconville@nhs.net
NUTS: UKE41
Internet address(es)
Main address: https://www.airdale-trust.nhs.uk
Address of the buyer profile: https://www.airdale-trust.nhs.uk
I.3) Communication
Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://atamis-1928.my.site.com/s/Welcome
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
WID Easy swab test (Pilot)
II.1.2) Main CPV code
85111800
II.1.3) Type of contract
Services
II.1.4) Short description
A contract to facilitate the implementation of the WID-easy endometrial cancer test at Airedale NHS Foundation Trust, The WID-easy test is a non-invasive, DNA methylation-based diagnostic tool designed to detect endometrial cancer with high sensitivity and specificity in women with Abnormal Uterine Bleeding (AUB). Its adoption aligns with NHS goals to improve early cancer detection, reduce diagnostic delays, and enhance patient experience. This contract will include the equipment needed to carry out this test as well as processing the tests and providing us with results.<br/><br/>This is an intended approach notice, providers can express their interest in being considered as the 'most suitable provider'<br/><br/>It is expected that this contract will run for an agreed trial period ranging from 3-6 months. To run from 12/04/2026.<br/>We expect the contract to be Valued between £30,000 and £40,000. We intend to award a contract using the most suitable provider process.<br/><br/>‘This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.’
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKE41
II.2.4) Description of the procurement
The implementation of the WID-easy endometrial cancer test at Airedale NHS Foundation Trust.<br/><br/>The WID-easy test is a non-invasive, DNA methylation-based diagnostic tool designed to detect endometrial cancer with high sensitivity and specificity in women with Abnormal Uterine Bleeding (AUB). Its adoption aligns with NHS goals to improve early cancer detection, reduce diagnostic delays, and enhance patient experience. <br/><br/>This contract will include the equipment needed to carry out this test as well as processing the tests and providing us with results.
II.3) Estimated date of publication of contract notice:
12/03/2026
Section IV: Procedure
IV.1) Description
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award<br/><br/>Decision makers:<br/>Sarah Walters<br/>Mr S Nallapeta<br/><br/>Our intention is to award this contract using the most suitable provider process<br/><br/>To be considered as the 'most suitable provider' we ask that you email claire.moules@nhs.net with in the 14 day period to start 12/03/2026 and finish 26/03/2026
VI.5) Date of dispatch of this notice
12/03/2026